Conferences
2–4 June 2015, University of Texas at Austin
Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench to Bedside
-
Novel influenza targets: polymerase, nucleoprotein and NS1 inhibitors
-
New inhibitors of influenza NA and M2
-
Inhibitors of HA function: DAS-181; fusion inhibitors; broad spectrum MAbs and smaller molecules targeting the HA stem
-
Antivirals and antibody-based therapies against other seasonal and emerging respiratory viruses
-
Host cell targets and determinants of host susceptibility: factors involved in virus replication or mediating the inflammatory response
-
Combination therapies
-
Clinical endpoints and regulatory issues